Akers Biosciences Inc (AKR)

 
This US company’s shares are traded by us as on the LSE. Income from them will not be treated as eligible for a reduced rate of tax. Learn more

AKR Share PerformanceMore

52 week high255.00 01/12/16
52 week low85.00 14/07/17
52 week change -112.50 (-52.94%)
4 week volume31,630 27/06/17

Media for (AKR)

Presenter: Ray, Akers, Co-Founder & Executive Chairman
29/07/2014
Presenter: Ray, Akers, Co-Founder & Executive Chairman
16/05/2014

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Holding(s) in Company

RNS Number: 6354L Akers Biosciences, Inc. 20 July 2017 July 20, 2017 Akers Biosciences, Inc. Holdings in Company Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (the "Company" or "Akers Bio"), a developer of rapid health information technologies, announces that it has become aware that Hudson Bay Master Fund, LTD has an interest in 632,080 common...

Board changes proposed at Akers Biosciences' AGM

Akers Biosciences has announced that a number of board changes would be proposed at its annual general meeting on 7 A...

Notice of AGM & Directorate Changes

RNS Number: 0430L Akers Biosciences, Inc. 14 July 2017 July 14, 2017 This announcement contains inside information Akers Biosciences, Inc. Notice of Annual General Meeting & Proposed Directorate Changes Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (the "Company" or "Akers Bio"), a developer of rapid health information technologies, announces th...

Form S-3 Registration Statement

RNS Number: 9601J Akers Biosciences, Inc. 03 July 2017 July 3, 2017 Akers Biosciences, Inc. Form S-3 Registration Statement Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (the "Company" or "Akers Bio"), a developer of rapid health information technologies, announces that its Form S-3 Registration Statement filed on April 19, 2017, as amended, in connectio...

Issue of Equity

RNS Number: 7278H Akers Biosciences, Inc. 09 June 2017 June 9, 2017 This announcement contains inside information Akers Biosciences, Inc. Issue of Equity Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (the "Company" or "Akers Bio"), a developer of rapid health information technologies, has received further conversion notices from warrant holders to ...

Akers Biosciences revenue down

Akers Biosciences revealed that total revenue fell to $667,250 in the first quarter of 2017, down from $738,023 in the first qu...

1st Quarter Results

RNS Number: 1984F Akers Biosciences, Inc. 16 May 2017 May 16, 2017 This announcement contains inside information Akers Biosciences, Inc. Financial Results for the First Quarter Ended March 31, 2017 Significant Cost Reductions and Progress Towards Breakeven Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), ("Akers", "Akers Bio" or the "Company"), a d...

Akers Biosciences schedules interims

Akers Biosciences has said it will publish its financial results in the United Kingdom for the three months ended March 31...

Equity Research (AKR)

Akers Biosciences Inc.
18/08/2016
Physiomics* (PYC.L) 0.04p £1.22m The computational systems biology services company applying simulations of cell behaviour to drug development to reduce the high attrition rates of clinical trials...
Akers Biosciences Inc.
11/08/2016
ValiRx (Val.L) 39p £4.37m The life science company, which focuses on clinical stage cancer therapeutic development has received regulatory approval for its VAL401 Phase IIB Clinical Trial in Georgia...

Latest discussion posts More

  • Re: RNS : new PIFA agreement

    Maybe turned the corner here
    30-Mar-2017
    Silveroil
  • RNS : new PIFA agreement

    Looks like a potentially lucrative agreement with a group of up to 300 New York hospitals to introduce the PIFA ...
    19-Dec-2016
    gretel
  • Exciting RNS just out

    Worth noting in particular that First Check are a subsidiary of the mighty Alere ...
    1-Dec-2016
    gretel

Users' HoldingsMore

Users who hold Akers Biosciences Inc also hold..
LLOYDS GRP.32%
ID:ISIN:GB00B142G99419%
NATIONAL GRID16%
BP16%
MORRISON (WM)12%

Codes & Symbols

ISINUS00973E1029
SymbolsAKR, LSE:AKR, AKR.L, AKR:LN, LON:AKR, XLON:AKR